VAERS reports by lot

GSK Varicella/Shingles lot H7AT2: VAERS reports

23 VAERS reports list lot H7AT2 as a GSK Varicella/Shingles vaccine, received between 2022-06-11 and 2023-08-25. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
23
Reports
4%
Marked serious
0
With a death outcome
8
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction1723%
General / Systemic (non-local)1622%
Musculoskeletal1115%
Allergic / Anaphylactic912%
Dermatological (non-injection-site)710%
Cardiac / Cardiovascular68%
Neurological45%
Respiratory23%
Gastrointestinal11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Illinois3
Florida2
Virginia2
Missouri2
New York1
North Carolina1
South Carolina1
Colorado1
Hawaii1
Texas1
Michigan1
Nevada1

Reports by month received

2022-064
2022-075
2022-085
2022-093
2022-103
2022-111
2022-121
2023-081

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.